Drug Trial Radar · NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
896
Actual
Start
Oct 1, 2025
Primary completion
Jan 14, 2028
Study completion Jan 13, 2032
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).
Conditions
- Colitis, Ulcerative
Interventions
IcotrokinraDrug
Icotrokinra tablet will be administered orally.
PlaceboDrug
Placebo tablet will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Double-blind (DB) Induction Study: Percentage of Adult Participants in Clinical Remission at Week I-12Time frame: At Week I-12
- DB Maintenance Study: Percentage of Adult Participants in Clinical Remission at Week M-40Time frame: At Week M-40
- Open-Label (OL) Maintenance Phase: Percentage of Adolescent Participants in Clinical Remission at Week M-40Time frame: At Week M-40
Locations
402 sites in 28 countries. Site status is shown where the registry gives one.
AZ Gastro Care
Chandler, Arizona
Research Solutions of Arizona
Litchfield Park, Arizona
Mayo Clinic
Scottsdale, Arizona
Clinnova Research
Anaheim, California
Southern California Research Center
Coronado, California
Om Research LLC
Lancaster, California
TLC Clinical Research Inc
Los Angeles, California
GastroIntestinal Bioscience
Los Angeles, California
Hoag Memorial Hospital
Newport Beach, California
Om Research LLC 2
Oxnard, California
Stanford Medicine Children's Health
Palo Alto, California
Clinical Applications Laboratories, Inc
San Diego, California
Medical Associates Research Group, Inc.
San Diego, California
University of California San Francisco
San Francisco, California
Peak Gastroenterology Associates
Colorado Springs, Colorado
Nuvance Health Danbury Hospital
Danbury, Connecticut
Connecticut Children's Medical Center
Hartford, Connecticut
American Institute of Research
Cutler Bay, Florida
Nature Coast Clinical Research
Inverness, Florida
Florida Research Institute
Lakewood Rch, Florida
GCP Clinical Research
Tampa, Florida
Atlanta Gastroenterology Associates
Atlanta, Georgia
Children's Center for Digestive Health Care
Atlanta, Georgia
Gastroenterolgy Associates of Central GA
Macon, Georgia
IU Health University Hospital
Indianapolis, Indiana
Cotton O'Neil Digestive Health Center
Topeka, Kansas
Tri-State Gastroenterology Assoc
Crestview Hills, Kentucky
Delta Research Partners, LLC
West Monroe, Louisiana
Chevy Chase Clinical Research
Chevy Chase, Maryland
Woodholme Gastroenterology Associates
Glen Burnie, Maryland
Westchester Putnam Gastroenterology
Carmel, New York
Inflammatory Bowel Disease Center at NYU Langone
New York, New York
Manhattan Clinical Research LLC
New York, New York
Icahn School of Medicine at Mount Sinai
New York, New York
Weill Cornell Medical College
New York, New York
Lenox Hill Hospital
New York, New York
New York Gastroenterology Associates
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Atrium Health
Charlotte, North Carolina
Digestive Disease Specialists Inc
Oklahoma City, Oklahoma
Showing 40 of 402 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.